DRI Healthcare delays London flotation, blaming Covid-19 meltdown

Aidan Gregory

February 28, 2020 01:45 pm

DRI_Covid_PA_575_375 — 28 February 2020, Hessen, Frankfurt/Main: An exchange trader at the Frankfurt Stock Exchange looks at his monitors. The most important German leading index, the Dax, fell by more than 5 percent in the morning. Concerns about a corona epidemic have been weighing on financial markets worldwide for days. Photo: Boris Roessler/dpa | Boris Roessler/DPA/PA Images

DRI Healthcare, the Canadian investment fund focused on pharmaceutical royalties, has postponed its $350m IPO on the London Stock Exchange, blaming the global equity market selloff caused by the spread of the Covid-19 virus.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request demo or Login

✔ 4,000 annual insights
✔ 700+ notes and long-form analyses
✔ 4 capital markets databases
✔ Daily newsletters across markets and asset classes
✔ 2 weekly podcasts

Topics

Equity IPOs Equity UK Europe EMEA Jefferies LLC

AG

Aidan Gregory